Stockreport

BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rare natural history study of patients living with inherited retinal diseases [Financial Po...

BAYER AG S/ADR  (BAYRY) 
NASDAQ:AMEX Investor Relations: investor.bayer.com
PDF •Collaboration will add a new multigene cohort of patients living with inherited retinal diseases •Data insights from the new study cohort will inform the future clinic [Read more]